ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 148 filers reported holding ACCELERON PHARMA INC in Q4 2016. The put-call ratio across all filers is 3.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $3,168,000 | -12.1% | 77,126 | -0.4% | 0.01% | -11.1% |
Q1 2019 | $3,606,000 | -0.3% | 77,426 | -6.8% | 0.01% | -10.0% |
Q4 2018 | $3,617,000 | -26.0% | 83,061 | -2.8% | 0.01% | -16.7% |
Q3 2018 | $4,891,000 | +24.8% | 85,461 | +5.8% | 0.01% | +20.0% |
Q2 2018 | $3,919,000 | -3.5% | 80,761 | -22.2% | 0.01% | -9.1% |
Q1 2018 | $4,061,000 | +0.3% | 103,861 | +8.9% | 0.01% | 0.0% |
Q4 2017 | $4,048,000 | +18.6% | 95,380 | +4.3% | 0.01% | +10.0% |
Q3 2017 | $3,414,000 | +52.1% | 91,480 | +23.8% | 0.01% | +42.9% |
Q2 2017 | $2,245,000 | +14.8% | 73,880 | 0.0% | 0.01% | +16.7% |
Q1 2017 | $1,956,000 | -3.1% | 73,880 | -6.6% | 0.01% | -14.3% |
Q4 2016 | $2,018,000 | -29.5% | 79,080 | 0.0% | 0.01% | -30.0% |
Q3 2016 | $2,862,000 | +66.2% | 79,080 | +56.0% | 0.01% | +66.7% |
Q2 2016 | $1,722,000 | +28.8% | 50,680 | 0.0% | 0.01% | +20.0% |
Q1 2016 | $1,337,000 | -45.1% | 50,680 | +1.4% | 0.01% | -44.4% |
Q4 2015 | $2,437,000 | +260.0% | 49,980 | +83.9% | 0.01% | +200.0% |
Q3 2015 | $677,000 | -33.1% | 27,180 | -15.0% | 0.00% | -25.0% |
Q2 2015 | $1,012,000 | -16.8% | 31,980 | 0.0% | 0.00% | 0.0% |
Q1 2015 | $1,217,000 | – | 31,980 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 42,030 | $3,777,000 | 6.01% |
Artal Group S.A. | 1,500,000 | $134,805,000 | 5.70% |
GREAT POINT PARTNERS LLC | 535,627 | $48,137,000 | 5.03% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 211,038 | $18,966,000 | 3.47% |
Cormorant Asset Management, LP | 825,000 | $74,143,000 | 3.44% |
Graticule Asia Macro Advisors LLC | 48,700 | $4,377,000 | 3.20% |
Avoro Capital Advisors LLC | 860,000 | $77,288,000 | 2.61% |
QVT Financial LP | 120,264 | $10,808,000 | 2.52% |
Ikarian Capital, LLC | 316,900 | $28,480,000 | 2.14% |
Avidity Partners Management LP | 166,000 | $14,918,000 | 2.06% |